Diversified Trust’s Bio-Rad Laboratories Class A BIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.37M Sell
4,897
-3,237
-40% -$932K 0.03% 352
2025
Q4
$2.46M Buy
8,134
+3
+0% +$936 0.05% 222
2025
Q3
$2.28M Buy
8,131
+22
+0.3% +$5.99K 0.05% 228
2025
Q2
$1.96M Buy
8,109
+23
+0.3% +$5.44K 0.04% 240
2025
Q1
$1.97M Buy
8,086
+5,170
+177% +$1.56M 0.05% 213
2024
Q4
$958K Buy
+2,916
New +$990K 0.02% 377
2024
Q2
Sell
-5,957
Closed -$2.06M 885
2024
Q1
$2.06M Buy
5,957
+4,299
+259% +$1.41M 0.06% 187
2023
Q4
$535K Buy
1,658
+143
+9% +$44.8K 0.02% 484
2023
Q3
$543K Sell
1,515
-1,049
-41% -$405K 0.02% 436
2023
Q2
$972K Sell
2,564
-23
-0.9% -$9.36K 0.04% 284
2023
Q1
$1.24M Sell
2,587
-893
-26% -$418K 0.05% 217
2022
Q4
$1.46M Sell
3,480
-330
-9% -$133K 0.06% 172
2022
Q3
$1.59M Buy
3,810
+302
+9% +$151K 0.07% 137
2022
Q2
$1.74M Buy
3,508
+235
+7% +$122K 0.07% 137
2022
Q1
$1.84M Buy
3,273
+859
+36% +$518K 0.06% 150
2021
Q4
$1.82M Buy
2,414
+87
+4% +$65.1K 0.06% 157
2021
Q3
$1.74M Sell
2,327
-145
-6% -$109K 0.06% 154
2021
Q2
$1.59M Buy
2,472
+414
+20% +$252K 0.06% 159
2021
Q1
$1.18M Buy
2,058
+702
+52% +$416K 0.05% 192
2020
Q4
$790K Buy
1,356
+212
+19% +$121K 0.03% 247
2020
Q3
$590K Buy
1,144
+35
+3% +$17.7K 0.03% 273
2020
Q2
$501K Buy
+1,109
New +$489K 0.03% 255
2014
Q2
$946K Buy
+7,905
New +$965K 0.08% 263
2013
Q4
$1.18M Hold
9,525
0.12% 170
2013
Q3
$1.12M Buy
9,525
+60
+0.6% +$7.08K 0.12% 183
2013
Q2
$1.06M Buy
+9,465
New +$1.11M 0.13% 166

Other funds holding BIO